Literature DB >> 33120287

Benign and malignant mimickers of infiltrative hepatocellular carcinoma: tips and tricks for differential diagnosis on CT and MRI.

Federica Vernuccio1, Giorgia Porrello2, Roberto Cannella3, Laura Vernuccio4, Massimo Midiri2, Lydia Giannitrapani5, Maurizio Soresi5, Giuseppe Brancatelli2.   

Abstract

Hepatocellular carcinoma (HCC) may have an infiltrative appearance in about 8-20% of cases. Infiltrative HCC can be a challenging diagnosis and it is associated with the worst overall survival among HCC patients. Infiltrative HCC is characterized by the spread of multiple minute nodules throughout the liver, without a dominant one, ultimately resulting into macrovascular invasion. On CT and MRI, infiltrative HCC appears as an ill-defined, large mass, with variable degree of enhancement, and satellite neoplastic nodules in up to 52% of patients. On MRI, it may show restriction on diffusion weighted imaging, hyperintensity on T2- and hypointensity on T1-weighted images, and, if hepatobiliary agent is used, hypointensity on hepatobiliary phase. Infiltrative HCC must be differentiated from other liver diseases, such as focal confluent fibrosis, steatosis, amyloidosis, vascular disorders of the liver, cholangiocarcinoma, and diffuse metastatic disease. In cirrhotic patients, the identification of vascular tumor invasion of the portal vein and its differentiation from bland thrombosis is of utmost importance for patient management. On contrast enhanced CT and MRI, portal vein tumor thrombosis appears as an enhancing thrombus within the portal vein, close to the main tumor and results into vein enlargement. The aim of this pictorial review is to show CT and MRI features that allow the diagnosis of infiltrative HCC and portal vein tumor thrombosis. A particular point of interest includes the tips and tricks for differential diagnosis with potential mimickers of infiltrative HCC.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Computed tomography; Differential diagnosis; Hepatocellular carcinoma; Liver neoplasms; Magnetic resonance imaging

Year:  2020        PMID: 33120287     DOI: 10.1016/j.clinimag.2020.10.011

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  9 in total

1.  Correlation of CT Perfusion Parameters and Vascular Endothelial Growth Factor (VEGF) and Basic Fibroblast Growth Factor (BFGF) in Patients with Primary Liver Cancer.

Authors:  Xiao-Min Li; Wei-Bin Chen; Jing Zhang; Li-Fang Ma; Qiang Li; Chao Feng; Xian-Hua Yuan; Li-Qing Kang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-24       Impact factor: 2.650

2.  Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular Carcinoma.

Authors:  Jingjun Huang; Wensou Huang; Meixiao Zhan; Yongjian Guo; Licong Liang; Mingyue Cai; Liteng Lin; Mingji He; Hui Lian; Ligong Lu; Kangshun Zhu
Journal:  J Hepatocell Carcinoma       Date:  2021-11-26

3.  Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma.

Authors:  Vincenza Granata; Roberta Fusco; Andrea Belli; Valentina Borzillo; Pierpaolo Palumbo; Federico Bruno; Roberta Grassi; Alessandro Ottaiano; Guglielmo Nasti; Vincenzo Pilone; Antonella Petrillo; Francesco Izzo
Journal:  Infect Agent Cancer       Date:  2022-03-28       Impact factor: 2.965

4.  The Value of Nuclear Magnetic Resonance in Liver Nodular Lesions.

Authors:  Si Chen; JiaLing Bao
Journal:  Contrast Media Mol Imaging       Date:  2022-08-11       Impact factor: 3.009

Review 5.  A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls.

Authors:  Federica De Muzio; Francesca Grassi; Federica Dell'Aversana; Roberta Fusco; Ginevra Danti; Federica Flammia; Giuditta Chiti; Tommaso Valeri; Andrea Agostini; Pierpaolo Palumbo; Federico Bruno; Carmen Cutolo; Roberta Grassi; Igino Simonetti; Andrea Giovagnoni; Vittorio Miele; Antonio Barile; Vincenza Granata
Journal:  Diagnostics (Basel)       Date:  2022-07-07

6.  Application of CT Imaging in Differential Diagnosis and Nursing of Endocrine Tumors.

Authors:  Xue Jiang; Weiwei Xu; Ying Zhao
Journal:  Contrast Media Mol Imaging       Date:  2022-08-08       Impact factor: 3.009

7.  Preoperative prediction of glypican-3 positive expression in solitary hepatocellular carcinoma on gadoxetate-disodium enhanced magnetic resonance imaging.

Authors:  Yidi Chen; Yun Qin; Yuanan Wu; Hong Wei; Yi Wei; Zhen Zhang; Ting Duan; Hanyu Jiang; Bin Song
Journal:  Front Immunol       Date:  2022-08-25       Impact factor: 8.786

Review 8.  State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma.

Authors:  Anna Castaldo; Davide Raffaele De Lucia; Giuseppe Pontillo; Marco Gatti; Sirio Cocozza; Lorenzo Ugga; Renato Cuocolo
Journal:  Diagnostics (Basel)       Date:  2021-06-30

Review 9.  Advances in liver US, CT, and MRI: moving toward the future.

Authors:  Federica Vernuccio; Roberto Cannella; Tommaso Vincenzo Bartolotta; Massimo Galia; An Tang; Giuseppe Brancatelli
Journal:  Eur Radiol Exp       Date:  2021-12-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.